SCHEMBL3501078

SCHEMBL3501078

N#CC(Cl)C(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28061642 0.77
SCHEMBL1343935 0.72
SCHEMBL7514639 0.69
SCHEMBL7512780 0.69
SCHEMBL7515259 0.69
SCHEMBL7518750 0.69
SCHEMBL7524037 0.69
SCHEMBL1180554 0.67
SCHEMBL28167115 0.67
SCHEMBL7517021 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2001448-A None JP disclosed
CN-113754561-B Production method of 2-chloroacrylonitrile and application of 2-chloroacrylonitrile in chlorfenapyr synthesis 山东新龙集团生物科技有限公司 2024-09-06 CN disclosed
CN-116096712-A Novel compounds NRG治疗有限公司 2023-05-09 CN disclosed
CN-113754561-A Production method of 2-chloropropene nitrile and application thereof in synthesis of chlorfenapyr 李通 2021-12-07 CN disclosed
CN-107709343-B Vaccine against streptococcus pneumoniae serotype 5 马克斯·普朗克科学促进学会 2021-05-18 CN disclosed
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed
EP-0280120-B1 ELECTROCHEMICAL PROCESS FOR THE EXCHANGE OF HALOGEN ATOMS IN AN ORGANIC COMPOUND HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-24 EP disclosed
JP-H021448-A PRODUCTION OF 3,3-DICHLOROACRYLONITRILE FUJI PHOTO FILM CO LTD 1990-01-05 JP disclosed
US-4800012-A Electrochemical process for the replacement of halogen atoms in an organic compound HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-24 US disclosed
EP-0280120-A1 Electrochemical process for the exchange of halogen atoms in an organic compound HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-31 EP disclosed
EP-0058033-B1 PROCESS FOR THE PRODUCTION OF 2,3-DICHLOROPROPIONITRILE MITSUI TOATSU CHEMICALS, Inc. (JP) 1984-01-25 EP disclosed
US-4418018-A Process for the production of 2,3-dichloropropionitrile MITSUI TOATSU CHEMICALS, INC. (JP) 1983-11-29 US disclosed
EP-0058033-A1 Process for the production of 2,3-dichloropropionitrile MITSUI TOATSU CHEMICALS, Inc. (JP) 1982-08-18 EP disclosed